Exercise for Normal-weight Obesity
(AHA-NWO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand and improve the health of men with normal-weight obesity, a condition characterized by a normal BMI but a high body fat percentage. Researchers seek to determine how different exercise types can enhance body composition and heart health. Participants will engage in either aerobic exercises, such as running, or resistance exercises, like weightlifting, for 12 weeks. Men who can commit to regular exercise and have either too little or too much body fat may be suitable candidates. As an unphased study, this trial provides a unique opportunity to contribute to valuable research that could refine exercise recommendations for better health.
Will I have to stop taking my current medications?
The trial excludes participants who regularly use prescribed medications that would significantly affect the study, so you may need to stop taking certain medications to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both aerobic and resistance exercises are generally safe for most people. Engaging in at least 150 minutes of aerobic exercise per week can reduce waist size and body fat without serious side effects, indicating that most people tolerate it well.
Studies indicate that resistance training helps build muscle and lose fat, and it can prevent muscle loss during weight loss. These studies have reported no major safety issues.
Both exercise types improve overall body composition and are considered safe treatments. It is important to consult a healthcare provider before starting any new exercise program, especially if there are health concerns.12345Why are researchers excited about this trial?
Researchers are excited about these exercise treatments for normal-weight obesity because they offer a personalized approach to fitness that targets the condition differently from standard dietary or pharmacological options. Aerobic exercise training focuses on improving cardiovascular health and endurance, while resistance exercise training aims to build muscle strength and mass. These methods are progressive and tailored to individual needs, potentially offering a more holistic and sustainable way to address body composition and metabolic health without relying on medication.
What evidence suggests that this trial's exercise treatments could be effective for normal-weight obesity?
This trial will compare Aerobic Exercise Training and Resistance Exercise Training for individuals with normal-weight obesity. Research has shown that performing aerobic exercise for at least 150 minutes a week can reduce waist size and body fat. This exercise type helps the body burn fat and improves overall fitness. Resistance exercise, in contrast, builds muscle and enables the body to burn calories more efficiently, even at rest. Both exercise types have demonstrated benefits for people with obesity, making them promising options for improving health and body composition in those with normal-weight obesity.12678
Who Is on the Research Team?
Sam Emerson, PhD
Principal Investigator
Oklahoma State University
Are You a Good Fit for This Trial?
This trial is for biological males who are willing to exercise, have a BMI between 18.5 - 24.9 or above 30, and body fat below 20% or above 25%. It's not for those with excessive alcohol, tobacco, vape use, illicit drugs, electrical implants like pacemakers, chronic health conditions or on medications impacting the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 12 weeks of progressive and individualized exercise training, either aerobic or resistance
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Aerobic Exercise Training
- Resistance Exercise Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oklahoma State University
Lead Sponsor
American Heart Association
Collaborator